Skip to main content

Human Cancer Proteoforms

Edited by:

Professor Andy Tao Yin Lau, PhD, Shantou University Medical College, China
Professor Amy Yan-Ming Xu, PhD, Shantou University Medical College, China 

Submission Status: Open   |   Submission Deadline: 28 February 2025

Cancer Cell International is calling for submissions to our Collection on Human Cancer Proteoforms.

Image credit: © [M] Christoph Burgstedt / Getty Images / iStock

About the Collection

Cancer Cell International is calling for submissions to our Collection on Human Cancer Proteoforms.

As of the first week of May 2024, according to the data from the UniProt Knowledgebase, the human proteome has a record of 20,434 canonical as well as 22,080 non-canonical protein isoforms. Over the years, with the advancement of proteomic and sequencing technologies, more and more novel proteoforms are characterized and studied. In addition, the discovery of protein-encoding lncRNAs and circRNAs has also contributed to the ever-increasing number of human proteoforms, in which all these should be taken into consideration for their underlying biological/physiological significance and how aberrant proteoform expressions might contribute to various diseases including cancer.
In this collection, we welcome Original Research and Review articles focusing on human cancer proteoform research. The themes that we wish to include, but are not limited to, are the following:
- Novel functions of cancer-specific human proteoforms
- Global/systematic analysis of human cancer proteoforms
- Cancer-specific proteoforms as diagnostic biomarkers or therapeutic targets
- The development of novel strategies to modulate proteoforms function in cancer therapy.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research and Review articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Human Cancer Proteoforms" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.